RubrYc Therapeutics announces Series A2 Preferred equity financing, collaboration, and RTX-003 license with iBio, Inc.

Must Read

RubrYc Therapeutics, Inc. (“RubrYc”) and iBio, Inc. (“iBio”, NYSEA: IBIO) announced today the closing of RubrYc’s Series A2 Preferred Financing, and concomitant License and Collaboration Agreements directed towards the …

Latest News

KRI Canopus to join search for Virgo Transport 8 victims: Basarnas

Banjarmasin, S Kalimantan (ANTARA) - The KRI Canopus warship will join the search for the victims of Virgo Transport...

More Articles Like This